137. Focal cortical dysplasia Clinical trials / Disease details

Clinical trials : 9 / Drugs : 5 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 51

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03198949 (ClinicalTrials.gov)	May 24, 2018	13/6/2017	A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refracto ...	A Prospective, Randomized, Double-blind, Placebo-controlled Cross Over Study Investigating the Anti- ...	Epilepsy and Focal Cortical Dysplasia II	Drug: Afinitor (everolimus)	Yonsei University	NULL	Completed	4 Years	40 Years	All	23	Phase 2	Korea, Republic of
2	NCT02451696 (ClinicalTrials.gov)	January 2014	8/10/2014	A Pilot Study To Evaluate The Effects of Everolimuson Brain mTOR Activity and Cortical Hyperexcitabi ...	A Pilot Study To Evaluate The Effects of Everolimuson Brain mTOR Activity and Cortical Hyperexcitabi ...	Epilepsy;Tuberous Sclerosis Complex;Focal Cortical Dysplasia	Drug: Everolimus	NYU Langone Health	NULL	Completed	2 Years	40 Years	All	15	Phase 2	United States

First Previous1Next Last